Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 225,371,601 papers from all fields of science
Search
Sign In
Create Free Account
NPM2 gene
Known as:
NPM2
, NUCLEOPHOSMIN/NUCLEOPLASMIN FAMILY, MEMBER 2
, nucleophosmin/nucleoplasmin 2
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
1 relation
Npm2 protein, mouse
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Re-evaluation of sperm histone region with NPM2
Kosuke Yamaguchi
,
Y. Okada
2017
Corpus ID: 90729231
2017
2017
Análisis de metilación en pacientes con leucemia mieloide crónica en diferentes instituciones médicas de Medellín
Claudia Yaneth Patiño Zapata
,
L. Pérez
,
L. Gómez
,
Luz Yaneth Orozco Jiménez
,
Kenny Mauricio Gálvez Cárdenas
,
Paola Andrea Acevedo Toro
2017
Corpus ID: 90783687
Background: chronic myeloid leukemia (CML) is a chronic myeloproliferative neoplasm characterized by the presence of the…
Expand
2014
2014
Prediction of Human Nucleoplasmin-3 Protein Structure and Active Sites
W. El‐Huneidi
,
Mohammed N Hamad
,
S. Arabia
2014
Corpus ID: 51797908
Nucleoplasmins are group of proteins involved in histone binding and play a crucial role in nucleosome assembly. There are four…
Expand
2010
2010
An optimal lot sizing and pricing planning in two-echelon supply chain
Jafar Naeij
,
H. Shavandi
2010
Corpus ID: 145043969
Article history: Received 1 January 2010 Received in revised form 10 March 2010 Accepted 10 April 2010 Available online 23 April…
Expand
2007
2007
Positron annihilation spectroscopy as a tool to develop self healing in aluminium alloys
S. Hautakangas
,
H. Schut
,
S. Zwaag
,
P. R. D. D. Castillo
,
N. Dijk
2007
Corpus ID: 98738678
Positron lifetime and Doppler broadening spectroscopy have been applied to probe the free volume generation (vacancies…
Expand
2006
2006
Epigenetic Silencing and Resistance to Imatinib Mesylate in CML
J. Issa
2006
Corpus ID: 70803897
Abstract : Resistance to Imatinib mesylate is emerging as a real clinical problem in the management of chronic myelogenous…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE